Search for: "Teva McKesson Corporation" Results 1 - 17 of 17
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 May 2024, 1:18 pm by Melissa Tremblay
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
13 Oct 2011, 7:23 am
A Nevada jury found three drug companies - Teva Parenteral Medicines Incorporated, Baxter Healthcare Corporation and McKesson Corporation - liable for distributing 50 and 100 milliliter vials of an anesthetic used during colonoscopies. [read post]
21 Jul 2021, 12:44 pm by Jon L. Gelman
The distributors named in the complaint were McKesson Corporation, Cardinal Health Inc., Amerisource Bergen Drug Corporation, and Rochester Drug Cooperative Inc. [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
In a major move, the third week of the ongoing New York State opioid trial saw the three largest U.S. drug distributors — McKesson Corporation, Cardinal Health Inc. and AmerisourceBergen Drug Corporation — agree mid-trial to settle claims with New York State, including both Suffolk County and Nassau County. [read post]
1 Dec 2010, 3:30 am
Baxter Healthcare Corporation, and McKesson Medical-Surgical, Inc. [read post]
31 Oct 2018, 5:09 pm by Kevin LaCroix
In the latest example of this type of lawsuit, a plaintiff shareholder has now filed a securities class action lawsuit against McKesson Corporation, asserting securities claims based on the company’s alleged involvement in a scheme to fix prices for generic drugs. [read post]
Suits have been filed across the US against companies such as Purdue, Walgreens, Rite Aid, Teva Pharmaceuticals, CVS, McKesson Corporation, Cardinal Health Inc., Johnson & Johnson and Mallinckrodt. [read post]
27 Jul 2011, 1:01 am by Marie Louise
  Highlights this week included: Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v. [read post]
18 Nov 2019, 4:24 am by Whittel & Melton, LLC
In recent lawsuits, the defendants have included McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, Covidien, Johnson & Johnson, CVS, Walgreens, and Rite Aid. [read post]
21 Oct 2021, 9:50 am by Simmons Hanly Conroy
To date, key results from the trial include: The three largest U.S. drug distributors — McKesson Corporation, Cardinal Health Inc. and AmerisourceBergen Drug Corporation — settled claims with New York State for a combined $1.18 billion Endo Pharmaceuticals and its subsidiaries agreed to a settlement with New York State, and Suffolk and Nassau Counties, totaling $50 million Johnson & Johnson settled with the state of New York for $263 million, and as part of… [read post]
21 Jun 2012, 11:46 am by Jon L. Gelman
Safety-Kleen Envirosystems Company by McKesson, and McKesson Corporation for itself55. [read post]
22 Jul 2022, 6:55 am by Levin Papantonio
According to the attorney, the corporation invested millions of dollars to drive efficiency. [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
The settlement with Endo follows recent settlements with McKesson Corporation, Cardinal Health Inc., AmerisourceBergen Drug Corporation, Walmart Inc., Rite Aid Corp, CVS Health Corp and Johnson & Johnson — bringing a total of more than $1 billion in recovered funds for New York State. [read post]
30 Nov 2017, 8:59 pm by Brenda Fulmer
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
23 Jan 2024, 9:01 pm by renholding
In 2022, Teva Pharmaceutical Industries Ltd. also settled shareholder allegations related to the price-fixing scheme for $420 million. 7.) [read post]
25 Jan 2023, 1:37 pm by Kevin LaCroix
In addition, and though not large enough to make the Top 100 list, the $141 million settlement in the McKesson Corporation case and the $95 million settlement in the Group Televisa. [read post]